Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5291277
Max Phase: Preclinical
Molecular Formula: C21H42N4O12
Molecular Weight: 542.58
Associated Items:
ID: ALA5291277
Max Phase: Preclinical
Molecular Formula: C21H42N4O12
Molecular Weight: 542.58
Associated Items:
Canonical SMILES: C[C@@H](O)[C@H]1O[C@H](O[C@H]2[C@H](O[C@@H]3O[C@H](CNC[C@@H](O)CO)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C21H42N4O12/c1-6(27)17-15(32)14(31)11(24)20(35-17)36-18-9(23)2-8(22)12(29)19(18)37-21-16(33)13(30)10(34-21)4-25-3-7(28)5-26/h6-21,25-33H,2-5,22-24H2,1H3/t6-,7-,8-,9+,10-,11-,12+,13-,14-,15+,16-,17-,18-,19-,20-,21+/m1/s1
Standard InChI Key: QRDMZRCZYKPTLI-UERROVCWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 542.58 | Molecular Weight (Monoisotopic): 542.2799 | AlogP: -7.28 | #Rotatable Bonds: 10 |
Polar Surface Area: 288.85 | Molecular Species: BASE | HBA: 16 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.16 | CX Basic pKa: 9.59 | CX LogP: -6.90 | CX LogD: -11.29 |
Aromatic Rings: 0 | Heavy Atoms: 37 | QED Weighted: 0.12 | Np Likeness Score: 1.39 |
1. Guchhait S, Khononov A, Pieńko T, Belakhov V, Baasov T.. (2023) Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases., 14 (6): [PMID:37312846] [10.1021/acsmedchemlett.3c00089] |
Source(1):